@FierceBiotech: Star fund manager Woodford calls in ex-FBI agent to probe Northwest Bio allegations. Report | Follow @FierceBiotech
@JohnCFierce: Bristol-Myers gets elotuzumab OK for multiple myeloma -- Believe that makes 39 for the year so far. More | Follow @JohnCFierce
@DamianFierce: Actually, inversions are ... good? More from the NYT | Follow @DamianFierce
> Servier is plotting major staffing cuts in its native France, looking to lay off 610 workers in response to sluggish sales. News
> China is ramping up its efforts to grow a local biopharma industry, reforming its regulatory structure to encourage in-country companies to compete with multinationals. More
> Merck KGaA plans to launch a new drug every year from 2017 forward, incoming CEO Stefan Oschmann said, starting with a Pfizer ($PFE)-partnered cancer immunotherapy. Story
Medical Device News
@FierceMedDev: ICYMI: Scientists make strides with real-time estrogen sensor. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Entellus wins FDA clearance for its endoscope to treat blocked sinus passages. Story | Follow @VarunSaxena2
@EmilyWFierce: JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. FiercePharma story | Follow @EmilyWFierce
> Wright Medical slapped with $11M verdict in bellwether case over metal hip implant. More
> Novartis' Alcon recalling more intraocular lenses due to reports of postoperative inflammation. Article
Pharma News
@FiercePharma: Report: Sanofi cooking up $12.7B animal health spinoff. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI: FDA warning letter says Dr Reddy's hid existence of QC testing lab where retesting was done. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI: Trump, Clinton lash out at Pfizer over Allergan deal. Article | Follow @CarlyHFierce
> Servier plots major layoffs in France after R&D setbacks, payer cuts. Story
> JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. More
> GSK's anticorruption overhaul in China may be hobbling sales. Article
Pharma Marketing News
> What caught our readers' fancy this year? Here's your top 10 FiercePharmaMarketing capsule. Editor's corner
> Amgen slaps $178K price on rare new leukemia drug Blincyto. More
> Top cancer doc takes to social media to fight rising prices. More
> Are Glaxo's China sales reforms putting it at a commercial disadvantage? More
> Big Pharma's bad rap made late-night TV, even before the Shkreli effect. More
Animal Health News
> Scientists roll out innovative health-tracking device for guide dogs. Report
> Report: Sanofi cooking up $12.7B animal health spinoff. Story
> Merck and Zoetis line up rival vaccines to fight new strain of dog flu. More
> Nexvet focuses first investor symposium on prospects for biotech in vet medicine. Article
> Petco abandons IPO plan in favor of $4.6B buyout. Item
Biotech IT News
> U.K. commits a further $375M to 100,000 Genomes Project. News
> Pfizer-Allergan merger raises questions about future of NuMedii deal. Item
> MediSapiens applies bioinformatics to find ideal leukemia treatment regimens. Report
> With PhIII trial coming up, Infinity strikes risk-based monitoring deal with Medidata. Story
> BGI slams brakes on Revolocity rollout, lays off staff in business rethink. Article